Advertisement

Topics

Synapse Biomedical, Inc. Company Profile

03:20 EDT 24th June 2018 | BioPortfolio

Founded in 2002, Synapse Biomedical's mission is to provide life transforming treatments through the commercialization of neurostimulation platforms and build a sustainable enterprise on the foundation of scientific & clinical findings that will provide meaningful value to patients, employees, community, and shareholders. Synapse is headquartered in Oberlin, Ohio and has a European Office in Enghien les Bains, France. For more information please visit www.synapsebiomedical.com.


News Articles [281 Associated News Articles listed on BioPortfolio]

Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)

Synapse Biomedical (www.synapsebiomedical.com), an innovator in neurostimulation and manufacturer of the NeuRx Diaphragm Pacing System®, announced today, the CE Mark approval for...

Remake, refill, reuse: Recycling at the synapse revealed

(Okinawa Institute of Science and Technology (OIST) Graduate University) OIST Researchers have shown that the speed of neurotransmitter recycling at the synapse is determined by the refilling speed of...

Superconducting synapse may be missing piece for 'artificial brains'

Researchers at the National Institute of Standards and Technology (NIST) have built a superconducting switch that "learns" like a biological system and could connect processors and store memories in ...

Engineers design artificial synapse for 'brain-on-a-chip' hardware

Engineers have designed an artificial synapse in such a way that they can precisely control the strength of an electric current flowing across it, similar to the way ions flow between neurons. The tea...

Spectrin is a mechanoresponsive protein shaping fusogenic synapse architecture during myoblast fusion

Critical period inhibition of NKCC1 rectifies synapse plasticity in the somatosensory cortex and restores adult tactile response maps in fragile X mice

Opinion: The NIH is in danger of losing its edge in creating biomedical innovations

Biomedical research in the U.S is flagging. Here's how we would fix it.

New Bionow Service Company of the Year Award to recognise excellence in specialist biomedical service provision and submission deadline extension

Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at http://www.bionow.co.uk/events/bionowannualawardsdinner....

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Serostim [EMD Serono, Inc.]

Serostim [somatropin (rDNA origin) for injection]

Desipramine hydrochloride [Sandoz Inc]

Desipramine Hydrochloride Tablets, USP

PubMed Articles [425 Associated PubMed Articles listed on BioPortfolio]

Molecular diversity underlying cortical excitatory and inhibitory synapse development.

The complexity and precision of cortical circuitries is achieved during development due to the exquisite diversity of synapse types that is generated in a highly regulated manner. Here, we review the ...

Sestd1 Encodes a Developmentally Dynamic Synapse Protein That Complexes With BCR Rac1-GAP to Regulate Forebrain Dendrite, Spine and Synapse Formation.

Molecular Dissection of Neuroligin 2 and Slitrk3 Reveals an Essential Framework for GABAergic Synapse Development.

In the brain, many types of interneurons make functionally diverse inhibitory synapses onto principal neurons. Although numerous molecules have been identified to function in inhibitory synapse develo...

A MIG-15/JNK-1 MAP kinase cascade opposes RPM-1 signaling in synapse formation and learning.

The Pam/Highwire/RPM-1 (PHR) proteins are conserved intracellular signaling hubs that regulate synapse formation and axon termination. The C. elegans PHR protein, called RPM-1, acts as a ubiquitin lig...

TRPM7 Is Required for Normal Synapse Density, Learning, and Memory at Different Developmental Stages.

The TRPM7 chanzyme contributes to several biological and pathological processes in different tissues. However, its role in the CNS under physiological conditions remains unclear. Here, we show that TR...

Clinical Trials [109 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain

BACKGROUND Shoulder pain is the third most common musculoskeletal disorder observed in primary care consultations after low back and neck pain. In the absence of successful outcome followi...

Companies [604 Associated Companies listed on BioPortfolio]

Synapse Biomedical, Inc.

Founded in 2002, Synapse Biomedical's mission is to provide life transforming treatments through the commercialization of neurostimulation platforms and build a sustainable enterp...

Synapse Biomedical Inc.

Synapse Biomedical, headquartered in Oberlin, Ohio, 30 miles west of Cleveland, was founded in 2002 to commercialize the NeuRx(TM) platform for treating a number of respiratory insufficiency condition...

Synapse Biomedical Inc

Synapse Biomedical, in collaboration with University Hospitals of Cleveland and Case Western Reserve University, is currently investigating the applications of the DPS System to people with respirator...

Synapse Wireless, Inc.

Synapse Wireless, Inc. (www.synapse-wireless.com) delivers proven, scalable M2M connectivity solutions designed to revolutionize business. Built on its award-winning SNAP® wire...

Synapse-partnership

Established in 1997 by Managing Director Adam Sherlock to provide technology services exclusively to clients in the pharmaceutical and healthcare industries, The Synapse Partnership Limited operates t...

More Information about "Synapse Biomedical, Inc." on BioPortfolio

We have published hundreds of Synapse Biomedical, Inc. news stories on BioPortfolio along with dozens of Synapse Biomedical, Inc. Clinical Trials and PubMed Articles about Synapse Biomedical, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synapse Biomedical, Inc. Companies in our database. You can also find out about relevant Synapse Biomedical, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record